PMID- 23813845 OWN - NLM STAT- MEDLINE DCOM- 20130927 LR - 20130722 IS - 1468-201X (Electronic) IS - 1355-6037 (Linking) VI - 99 IP - 16 DP - 2013 Aug TI - Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation. PG - 1158-65 LID - 10.1136/heartjnl-2013-304185 [doi] AB - OBJECTIVES: This study was designed to delineate the role of implantable cardioverter defibrillator (ICD) therapy for the primary and secondary prevention of sudden cardiac death in patients listed for heart transplantation. SETTING: Retrospective observational multicentre study. PATIENTS: 1089 consecutive patients listed for heart transplantation in two tertiary heart transplant centres were enrolled. Of 550 patients (51%) on the transplant list with an ICD, 216 had received their ICD for the primary prevention of sudden cardiac death and 334 for secondary prevention. 539 patients did not receive an ICD. INTERVENTION: Treatment with or without an ICD was left to the discretion of the heart failure specialist. MAIN OUTCOME MEASURE: All-cause mortality. RESULTS: ICDs appear to be associated with a reduction in all-cause mortality in patients implanted with the device for primary and secondary prevention compared to those without an ICD despite a median time on the waiting list of only 8 months (estimated 1-year: 88+/-3% vs. 77+/-3% vs. 67+/-3%; p=0.0001). A Cox regressional hazard model (corrected for age, sex, underlying heart disease, atrial fibrillation, cardiac resynchronisation therapy, New York Heart Association (NYHA) class, ejection fraction, co-medication and year of listing) suggested an independent beneficial effect of ICDs that was most pronounced in patients who had received an ICD for primary prevention (HR 0.4, 95% CI 0.19 to 0.85; p=0.016). CONCLUSIONS: ICD implantation appears to be associated with an immediate and sustained survival benefit for patients awaiting heart transplantation. FAU - Frohlich, Georg M AU - Frohlich GM AD - Cardiovascular Division, University Hospital Zurich, Raemistrasse 100, Zurich CH-8091, Switzerland. FAU - Holzmeister, Johannes AU - Holzmeister J FAU - Hubler, Michael AU - Hubler M FAU - Hubler, Samira AU - Hubler S FAU - Wolfrum, Mathias AU - Wolfrum M FAU - Enseleit, Frank AU - Enseleit F FAU - Seifert, Burkhardt AU - Seifert B FAU - Hurlimann, David AU - Hurlimann D FAU - Lehmkuhl, Hans B AU - Lehmkuhl HB FAU - Noll, Georg AU - Noll G FAU - Steffel, Jan AU - Steffel J FAU - Falk, Volkmar AU - Falk V FAU - Luscher, Thomas F AU - Luscher TF FAU - Hetzer, Roland AU - Hetzer R FAU - Ruschitzka, Frank AU - Ruschitzka F LA - eng PT - Journal Article PT - Multicenter Study DEP - 20130627 PL - England TA - Heart JT - Heart (British Cardiac Society) JID - 9602087 SB - IM MH - Adult MH - Arrhythmias, Cardiac/diagnosis/etiology/mortality/*prevention & control MH - Death, Sudden, Cardiac/etiology/*prevention & control MH - *Defibrillators, Implantable MH - Electric Countershock/adverse effects/*instrumentation/mortality MH - Female MH - Germany MH - Heart Failure/complications/diagnosis/mortality/surgery/*therapy MH - *Heart Transplantation MH - Humans MH - Kaplan-Meier Estimate MH - Logistic Models MH - Male MH - Middle Aged MH - Primary Prevention/*instrumentation/methods MH - Propensity Score MH - Proportional Hazards Models MH - Retrospective Studies MH - Risk Factors MH - Secondary Prevention/*instrumentation/methods MH - Switzerland MH - Tertiary Care Centers MH - Time Factors MH - Treatment Outcome MH - *Waiting Lists/mortality EDAT- 2013/07/03 06:00 MHDA- 2013/09/28 06:00 CRDT- 2013/07/02 06:00 PHST- 2013/07/02 06:00 [entrez] PHST- 2013/07/03 06:00 [pubmed] PHST- 2013/09/28 06:00 [medline] AID - heartjnl-2013-304185 [pii] AID - 10.1136/heartjnl-2013-304185 [doi] PST - ppublish SO - Heart. 2013 Aug;99(16):1158-65. doi: 10.1136/heartjnl-2013-304185. Epub 2013 Jun 27.